Dear Colleagues,

Register to reserve your virtual seat now! Join us for each of the 4 upcoming webinars of the Retina LIVE: Diabetic Retinopathy - Webinar Series and connect with faculty in real-time Q&A sessions powered by RetinaCME®.

Early diagnosis and prompt treatment with intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy are effective in the prevention of vision loss in individuals with diabetic retinopathy (DR). Continuing advances in retinal imaging are providing enhanced approaches for the effective screening and accurate staging of disease, which in turn provides guidance for patient referral to specialists, therapy selection, and assessment of disease progression. Furthermore, management of the systemic manifestations of diabetes along with optimal incorporation of anti-VEGF therapies into treatment protocols have the potential to improve visual outcomes in patients with DR. Within this webinar series, experts in the field will discuss updates on DR classification, differentiate the options for imaging the DR patient, evaluate whether systemic control influences DR outcomes, and provide guidance for applying treatment outcomes from DR studies to real-life clinical practice. Each webinar will also include an interactive question and answer session allowing for expert guidance and clarification of optimal management protocols for patients with DR.


Update on DR Classification—Wednesday, November 28th
7:00 pm EST

Activity Chair: Rishi P. Singh, MD | Faculty: Amir H. Kashani, MD, PhD
Register →

Topics Include:

  • Effective screening and staging of disease
  • Use of disease severity scales and ancillary testing
  • When to refer


Imaging the DR Patient—Wednesday, December 5th
8:00 pm EST

Activity Chair: Rishi P. Singh, MD | Faculty: Justis P. Ehlers, MD
Register →

Topics Include:

  • Differentiating the options – color fundus photography, fluorescein angiography, ultrawide field imaging, OCT
  • Assessing disease progression
  • Monitoring effectiveness of therapy


Does Systemic Control Matter on DR Outcomes—Sunday, December 9th
6:00 pm EST

Activity Chair: Rishi P. Singh, MD | Faculty: Dilsher S. Dhoot, MD
Register →

Topics Include:

  • Management of systemic manifestations of diabetes
  • Getting the patient on board with glycemic control
  • Working with primary care to improve communication and coordination of care
  • Comorbidities associated with diabetes and how to manage


Applying Treatment Outcomes from DR Studies to Real Life Clinical Practice—Wednesday, December 12th
8:00 pm EST

Activity Chair: Rishi P. Singh, MD | Faculty: Charles C. Wykoff, MD, PhD
Register →

Topics Include:

  • 1 year and 2 year data on DME – What have we learned about treatment selection? What are the implications of 2-year data?
  • PDR and NPDR – a closer look at DR treatment with ranibizumab, aflibercept, and bevacizumab in PDR and NPDR


Target Audience: The intended audience for this activity is retina specialists and other health care professionals involved in the treatment of patients with DR.

Learning Objectives: Upon successful completion of this activity, participants should be better able to:

  • Review the classification criteria for diabetic retinopathy and their relevance to disease management strategies.
  • Assess the utility of new imaging techniques in the diagnosis, assessment, and monitoring of diabetic retinopathy.
  • Investigate the effects of systemic control of diabetes on the outcomes of diabetic retinopathy treatment, as observed in clinical trials.
  • Analyze the findings of Protocol T and their relevance to clinical practice.
  • Describe patient education techniques and tools that can effectively improve adherence and compliance to therapy.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity series for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.